Side-by-side comparison of AI visibility scores, market position, and capabilities
Vancouver BC premium athletic apparel (NASDAQ: LULU) ~$10.6B FY2024 revenue (+11%); women's yoga apparel leader, China +41%, US slowdown, men's 22%+ of revenue, competing with Nike and Alo Yoga.
lululemon athletica inc. is a Vancouver, British Columbia-based premium athletic apparel company — publicly traded on the NASDAQ (NASDAQ: LULU) as an S&P 500 Consumer Discretionary component — designing, making, and distributing technical athletic apparel (yoga, run, train, swim, golf) and lifestyle products for women (primary market), men (growing), and youth through 700+ company-owned retail stores and e-commerce at lululemon.com through approximately 36,000 employees. In fiscal year 2024 (ending February 2025), lululemon reported revenues of approximately $10.6 billion (+11% year-over-year), continuing its decade-long consistent double-digit revenue growth as the brand expanded internationally (China mainland growing 41% in FY2024, Rest of World growing 28%) while US growth slowed to low single digits as the premium yoga-adjacent apparel market reached maturation levels in core US metro markets. CEO Calvin McDonald's strategy has focused on building the international business (China, Europe, rest of world) to replicate the North American penetration that drove lululemon's exceptional 2014-2023 growth, while managing the Mirror connected fitness acquisition write-off ($500 million full goodwill impairment of the Mirror home fitness acquisition completed in June 2020 for $500 million — mirror business essentially wound down by 2023) and navigating US market saturation challenges that required product innovation investment to sustain domestic revenue growth. lululemon's core women's leggings business (Align, Wunder Under, Fast and Free pants — $100-148 price point, premium Luon and Everlux fabric technology) anchors the brand's category authority in performance athletic bottoms.
Women's health medtech with $3.9B FY2024 revenue; 3D Genius Mammography market leader; Panther molecular diagnostics platform; annual screening guidelines expand mammography TAM by ~30%.
Hologic is a global medical technology company uniquely dedicated to women's health, founded in 1985 and headquartered in Marlborough, Massachusetts, trading on Nasdaq (HOLX). The company generated approximately $3.9 billion in revenues for fiscal year 2024 (ending September 28) under CEO Stephen MacMillan, who has led Hologic since 2013 and transformed it from a single-product mammography company into a diversified women's health platform. Hologic's four business segments serve distinct clinical needs: Diagnostics (Panther molecular testing platform, cervical health testing, and COVID-19 diagnostics), Breast Health (3D mammography, breast biopsy guidance systems, radiation therapy), Surgical (NovaSure endometrial ablation, MyoSure fibroid removal, and minimally invasive hysteroscopy), and Skeletal Health (bone density measurement).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.